M

matookerepublic.com

@matookerepublic Tue, 06 Jan 2026 00:20:26

Uganda approves twice-yearly HIV Prevention injection Lenacapavir

Uganda's National Drug Authority (NDA) has approved Lenacapavir, a long-acting HIV prevention injection developed by US pharmaceutical company Gilead Sciences, in a significant boost to the country's fight against HIV/AIDS. Announcing the decision, the NDA described the approval as a major step forward in HIV prevention. Lenacapavir is taken just twice a year and is The post Uganda approves twice-yearly HIV Prevention injection Lenacapavir first appeared on Matooke Republic.

read more

Other Headlines